| Ali Shishehgar, | |
|
132 S Anita Dr Ste 310, Orange, CA 92868-3317 | |
| (877) 778-3773 | |
| Not Available |
| Full Name | Ali Shishehgar |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 132 S Anita Dr Ste 310, Orange, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013514314 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 65874 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ali Shishehgar, 132 S Anita Dr Ste 310, Orange, CA 92868-3317 Ph: (877) 778-3773 | Ali Shishehgar, 132 S Anita Dr Ste 310, Orange, CA 92868-3317 Ph: (877) 778-3773 |
News Archive
Infants born prematurely face challenges in developing the complex, interrelated skills needed for effective feeding.
There is a lesson in this unexpected juxtaposition nevertheless: No nation can safely base its tax and spending plans on inflexible commitments. Political life, both domestic and international, is too unpredictable. Yet U.S. government spending is mostly on autopilot. The government is scheduled to lay out $3.8 trillion this fiscal year -; 70 percent of which will go to mandatory-spending programs, chiefly Social Security, Medicare, Medicaid and interest on the federal debt. Mr. Obama's plan for fiscal 2015 does not change this; it would increase overall spending slightly, paying for it with selected tax increases, while shifting money among priorities here and there. But these tweaks would take place within the same 30 percent of discretionary spending that the current budget contains (3/4).
Professor Hannes Lohi's research group at the University of Helsinki and Folkh-lsan Research Center, Finland, has identified a mutation in CNGB1 gene, causing progressive retinal atrophy (PRA) in the Phalene and Papillon dog breeds.
Santarus, Inc. today announced that its Phase III clinical study to evaluate the safety and efficacy of the investigational drug, rifamycin SV MMX, met the primary endpoint of reducing time to last unformed stool (TLUS) in patients with travelers' diarrhea.
› Verified 8 days ago
Joanne S Lau, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 600 City Pkwy W Ste 800, Orange, CA 92868 Phone: 714-347-5858 | |
Mrs. Stephanie Tram Nguyen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1201 W La Veta Ave, Orange, CA 92868 Phone: 714-509-8856 Fax: 714-509-4371 | |
Travis Stucky, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1538 E Chapman Ave, Orange, CA 92866 Phone: 714-288-1790 | |
Dr. William Robert Truong, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1100 W Stewart Dr, Orange, CA 92868 Phone: 714-771-8000 | |
Christine Jung, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 600 City Pkwy W Ste 800, Orange, CA 92868 Phone: 657-236-5153 Fax: 714-560-7627 | |
Terrie Liu Williams, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1100 W Stewart Dr, Orange, CA 92868 Phone: 714-771-8968 |